TARA MARSHALL: Open Payments
NPI 1942782388 · HUNTINGTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 17 payments from 11 companies in 2025. Trend: 2023 $46 · 2024 $48 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $107 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $73 |
| Madrigal Pharmaceuticals | 3 | $60 |
| ABBVIE INC. | 2 | $52 |
| Novo Nordisk Inc | 2 | $44 |
| QOL Medical, LLC | 1 | $25 |
| Ardelyx, Inc. | 1 | $24 |
| GENZYME CORPORATION | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $19 |
Products named: Livdelzi, XIFAXAN, REZDIFFRA, Wegovy, RINVOQ, Sucraid, IBSRELA, LINZESS.
Industry payments across WV — which companies pay providers there.
